SARS-CoV-2 infection Trials in Salt Lake City, United States
Conditions / SARS-CoV-2 infection / Salt Lake City, United States
Clinical trials for SARS-CoV-2 infection investigate a range of treatment strategies and patient populations.
17 total trials for this combination
Showing top 10 of 17 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07222384 | A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19 | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04955626 | To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age. | COMPLETED | PHASE3 |
| NCT07300839 | A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age | RECRUITING | PHASE3 |
| NCT05997290 | A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals | COMPLETED | — |
| NCT04754594 | To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older | COMPLETED | PHASE2/PHASE3 |
| NCT04368728 | Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals | COMPLETED | PHASE2/PHASE3 |
| NCT04887948 | Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2 | COMPLETED | PHASE3 |
| NCT04924660 | Novel Experimental COVID-19 Therapies Affecting Host Response | COMPLETED | PHASE2/PHASE3 |
| NCT05472038 | A Study to Learn About New COVID-19 RNA Vaccine Candidates in COVID-19 Vaccine-Experienced Healthy Individuals | COMPLETED | PHASE2/PHASE3 |
| NCT05997290 | A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals | COMPLETED | — |